Case Report: Treatment of systemic mastocytosis with sunitinib

Mast cell activation disease typically presents as chronic multisystem polymorbidity of generally inflammatory ± allergic theme.  Presently, treatment of the rare, cytoproliferative variant systemic mastocytosis employs empirically selected therapies to impede mast cell mediator production and actio...

Descripción completa

Detalles Bibliográficos
Autores principales: Molderings, Gerhard J., Afrin, Lawrence B., Hertfelder, Hans-Jörg, Brettner, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946163/
https://www.ncbi.nlm.nih.gov/pubmed/29770197
http://dx.doi.org/10.12688/f1000research.13343.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946163/
https://www.ncbi.nlm.nih.gov/pubmed/29770197
http://dx.doi.org/10.12688/f1000research.13343.1

Ejemplares similares